Company Profile
Amphastar Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- AMPH
- Exchange:
- NASDAQ
- Sector:
- 注射剂,吸入制剂,口服制剂
- Location:
- Headquartered in the United States and listed on NASDAQ, Amphastar Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
19.53 USD (+6.55%)
Close
Last updated: June 23, 2026 at 00:00
861.13M USD
Market cap
Why the stock is moving
AMPH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Amphastar Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Amphastar Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Amphastar Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Amphastar Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Amphastar Pharmaceuticals, Inc. (AMPH)?
Amphastar Pharmaceuticals, Inc. (AMPH) most recently closed at 19.53 USD, a +6.55% move versus the previous session.
What is the market cap of Amphastar Pharmaceuticals, Inc. (AMPH)?
Amphastar Pharmaceuticals, Inc. currently has a market capitalization of 861.13M USD on BioPharmSignal.
What does Amphastar Pharmaceuticals, Inc. do?
Amphastar Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is AMPH stock listed?
Amphastar Pharmaceuticals, Inc. (AMPH) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Amphastar Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., 注射剂,吸入制剂,口服制剂.
What is Amphastar?
Amphastar Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Amphastar Pharmaceuticals, Inc. targeting with Amphastar?
Amphastar Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Amphastar Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.